Research finds trees in urban spaces promote heart health An analysis of 10 years of hospitalisation and death data shows urban green space, particularly trees, can reduce cardiovascular disease risk.
RACGP Foundation rewards outstanding research Preventive care in the elderly, paediatric care, climate change and rural workforce: the broad focus areas of this year’s winning projects.
Rheumatic fever and heart disease Dhineli Perera chats to infectious diseases specialist Professor Anna Ralph about acute rheumatic fever and rheumatic heart disease. Who gets these conditions, how are they diagnosed, and how do we manage them?
Survey hints at increasing long COVID burden Half of the nearly 2200 people surveyed by Lung Foundation Australia reported ongoing symptoms more than four weeks after their initial infection.
SGLT2 inhibitors for kidney and heart disease Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease.
Healthcare services for heart failure patients underutilised: Research A new study suggests half a million Australians with heart failure are missing out on optimal care, presenting an ‘opportunity’ for GPs.
The role of clinical decision tools in chronic disease care Through RACGP Foundation-supported research, a GP academic is hoping to put an end to ‘blanket recommendations’ for chronic disease.
Unpacking diabetes and the heart SPONSORED: New medicines and emerging strategies to profile risk offer more options than ever to manage CVD risk in people with diabetes.
Australian death rate in 2020 lowest on record: AIHW All-cause mortality rates declined by 7.7% from 2019, but there was one PHN where 67% of deaths were still considered ‘premature’.
Study looks at digital approach to secondary heart attack prevention New Australian research finds post-hospitalisation text messaging program can help improve lifestyle risk factors for heart attack survivors.